Literature DB >> 20309627

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.

Patricia G Moorman1, Edwin S Iversen, P Kelly Marcom, Jeffrey R Marks, Frances Wang, Eunjung Lee, Giske Ursin, Timothy R Rebbeck, Susan M Domchek, Banu Arun, Lisa Susswein, Claudine Isaacs, Judy E Garber, Kala Visvanathan, Constance A Griffin, Rebecca Sutphen, Jennifer Brzosowicz, Stephen Gruber, Dianne M Finkelstein, Joellen M Schildkraut.   

Abstract

The incomplete penetrance of mutations in BRCA1 and BRCA2 suggests that some combination of environmental and genetic factors modifies the risk of breast cancer in mutation carriers. This study sought to identify possible interactions between established breast cancer risk factors and BRCA1 or BRCA2 mutations using a case-only study design. Breast cancer cases that had been tested for BRCA1 and BRCA2 mutations were identified from 11 collaborating centers. Comparisons of reproductive and lifestyle risk factors were made between women with breast cancer who were positive for BRCA1 mutations (n = 283), BRCA2 mutations (n = 204), or negative for both BRCA1 and BRCA2 mutations (n = 894). Interaction risk ratios (IRRs) were calculated using multinominal logistic regression models. Compared with non-carriers, statistically significant IRRs were observed for later age at menarche among BRCA2 mutation carriers, for a greater number of pregnancies among both BRCA1 and BRCA2 mutation carriers, and for alcohol use among BRCA1 mutation carriers. Our data suggest that the risk for breast cancer among BRCA1 or BRCA2 carriers may be modified by reproductive characteristics and alcohol use. However, our results should be interpreted cautiously given the overall inconsistency in the epidemiologic literature on modifiers of BRCA1 and BRCA2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309627      PMCID: PMC2925060          DOI: 10.1007/s10549-010-0842-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  30 in total

1.  Potential misinterpretation of the case-only study to assess gene-environment interaction.

Authors:  S Schmidt; D J Schaid
Journal:  Am J Epidemiol       Date:  1999-10-15       Impact factor: 4.897

2.  Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Steven A Narod; Marie-Pierre Dubé; Jan Klijn; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Diane Provencher; Ketil Heimdal; Pal Moller; Mark Robson; Kenneth Offit; Claudine Isaacs; Barbara Weber; Eitan Friedman; Ruth Gershoni-Baruch; Gad Rennert; Barbara Pasini; Theresa Wagner; Mary Daly; Judy E Garber; Susan L Neuhausen; Peter Ainsworth; Hakan Olsson; Gareth Evans; Michael Osborne; Fergus Couch; William D Foulkes; Ellen Warner; Charmaine Kim-Sing; Olufunmilayo Olopade; Nadine Tung; Howard M Saal; Jeffrey Weitzel; Sofia Merajver; Marion Gauthier-Villars; Helena Jernstrom; Ping Sun; Jean-Sebastien Brunet
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

3.  Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.

Authors:  J S Brunet; P Ghadirian; T R Rebbeck; C Lerman; J E Garber; P N Tonin; J Abrahamson; W D Foulkes; M Daly; J Wagner-Costalas; A Godwin; O I Olopade; R Moslehi; A Liede; P A Futreal; B L Weber; G M Lenoir; H T Lynch; S A Narod
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

4.  Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.

Authors:  H Jernström; C Lerman; P Ghadirian; H T Lynch; B Weber; J Garber; M Daly; O I Olopade; W D Foulkes; E Warner; J S Brunet; S A Narod
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

5.  Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies.

Authors:  W W Piegorsch; C R Weinberg; J A Taylor
Journal:  Stat Med       Date:  1994-01-30       Impact factor: 2.373

6.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

Authors: 
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

7.  Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?

Authors:  G Ursin; B E Henderson; R W Haile; M C Pike; N Zhou; A Diep; L Bernstein
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

8.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Authors:  Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

Review 9.  Prognosis of BRCA-associated breast cancer: a summary of evidence.

Authors:  L Bordeleau; S Panchal; P Goodwin
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

10.  BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Authors:  Laufey Tryggvadottir; Elinborg J Olafsdottir; Sigfridur Gudlaugsdottir; Steinunn Thorlacius; Jon G Jonasson; Hrafn Tulinius; Jorunn E Eyfjord
Journal:  Breast Cancer Res       Date:  2003-06-24       Impact factor: 6.466

View more
  16 in total

1.  Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study.

Authors:  Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

2.  Does and should breast cancer genetic counselling include lifestyle advice?

Authors:  Akke Albada; Madelèn Vernooij; Liesbeth van Osch; Anouk Pijpe; Sandra van Dulmen; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Risk factors for ovarian cancers with and without microsatellite instability.

Authors:  Yakir Segev; Tuya Pal; Barry Rosen; John R McLaughlin; Thomas A Sellers; Harvey A Risch; Shiyu Zhang; Sun Ping; Steven A Narod; Joellen Schildkraut
Journal:  Int J Gynecol Cancer       Date:  2013-07       Impact factor: 3.437

4.  Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.

Authors:  Monique A de Bruin; Ava Kwong; Benjamin A Goldstein; Jafi A Lipson; Debra M Ikeda; Lisa McPherson; Bhavna Sharma; Ani Kardashian; Elizabeth Schackmann; Kerry E Kingham; Meredith A Mills; Dee W West; James M Ford; Allison W Kurian
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

5.  Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.

Authors:  Paul A James; Sarah Sawyer; Samantha Boyle; Mary-Anne Young; Serguei Kovalenko; Rebecca Doherty; Joanne McKinley; Kathryn Alsop; Victoria Beshay; Marion Harris; Stephen Fox; Geoffrey J Lindeman; Gillian Mitchell
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

6.  Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.

Authors:  Murray Joseph Casey; Todd A Salzman
Journal:  Linacre Q       Date:  2018-07-20

Review 7.  Management of familial cancer: sequencing, surveillance and society.

Authors:  Nardin Samuel; Anita Villani; Conrad V Fernandez; David Malkin
Journal:  Nat Rev Clin Oncol       Date:  2014-10-14       Impact factor: 66.675

8.  Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence.

Authors:  Jasmine A McDonald; Abhishek Goyal; Mary Beth Terry
Journal:  Curr Breast Cancer Rep       Date:  2013-09

9.  Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium.

Authors:  Nadine Andrieu; David E Goldgar; Hongyan Li; Mary Beth Terry; Antonis C Antoniou; Kelly-Anne Phillips; Karin Kast; Thea M Mooij; Christoph Engel; Catherine Noguès; Dominique Stoppa-Lyonnet; Christine Lasset; Pascaline Berthet; Veronique Mari; Olivier Caron; Daniel Barrowdale; Debra Frost; Carole Brewer; D Gareth Evans; Louise Izatt; Lucy Side; Lisa Walker; Marc Tischkowitz; Mark T Rogers; Mary E Porteous; Katie Snape; Hanne E J Meijers-Heijboer; Johan J P Gille; Marinus J Blok; Nicoline Hoogerbrugge; Mary B Daly; Irene L Andrulis; Saundra S Buys; Esther M John; Sue-Anne McLachlan; Michael Friedlander; Yen Y Tan; Ana Osorio; Trinidad Caldes; Anna Jakubowska; Jacques Simard; Christian F Singer; Edith Olah; Marie Navratilova; Lenka Foretova; Anne-Marie Gerdes; Marie-José Roos-Blom; Brita Arver; Håkan Olsson; Rita K Schmutzler; John L Hopper; Roger L Milne; Douglas F Easton; Flora E Van Leeuwen; Matti A Rookus
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-02       Impact factor: 4.254

10.  Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Charmaine Kim-Sing; Susan Neuhausen; Rochelle Demsky; William D Foulkes; Parviz Ghadirian; Nadine Tung; Peter Ainsworth; Leigha Senter; Beth Karlan; Andrea Eisen; Charis Eng; Jeffrey Weitzel; Dawna M Gilchrist; Joanne L Blum; Dana Zakalik; Christian Singer; Taya Fallen; Ophira Ginsburg; Tomasz Huzarski; Ping Sun; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.